Navigation Links
Adeona Becomes Synthetic Biologics, Inc.
Date:2/16/2012

ANN ARBOR, Mich., Feb. 16, 2012 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, announced today that it received approval at yesterday's special meeting of stockholders to change its corporate name to Synthetic Biologics, Inc. It is expected that the Company's shares will start trading under its new name and stock ticker symbol, "SYN", effective as of market open today, Thursday, February 16, 2012. Synthetic Biologics' common stock has been assigned a new CUSIP number of 87163U102 in connection with the name change. Outstanding stock certificates are not affected by the name change and will not need to be exchanged.

Following the special meeting, the Company filed an amendment to its Articles of Incorporation with the Nevada Secretary of State to effect the name change.

About Synthetic Biologics, Inc.

Synthetic Biologics is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. Synthetic Biologics is developing, or has partnered the development of, product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis (ALS). For more information, please visit Synthetic Biologics' website at www.syntheticbiologics.com.


'/>"/>
SOURCE Synthetic Biologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Adeona Announces Initiation of Phase II Clinical Trial of Trimesta™ for Cognitive Dysfunction in Multiple Sclerosis
2. Adeona CEO to Present at the NYC Medtech Forum
3. Adeona Announces Positive Alzheimers Subgroup Analysis that Supports Additional Clinical Study of Proprietary Zinc-Based Therapy
4. Adeonas Multiple Sclerosis Clinical Trial Receives $1,594,553 Grant
5. Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
6. Bacterin Becomes Premier Founding Sponsor of RMECs New Osteobiologics Registry
7. If oxygen becomes the undoing of proteins
8. AWAC Becomes inVentiv Medical Management™
9. Robin Powell Becomes President at Biotech Leader Divine Skin (DSKX)
10. Research Dynamics Becomes DATATRAK Connect Partner
11. Americord Registry Becomes First Cord Blood Bank to Offer Placenta Preservation, Advancing Cord Blood Stem Cell Therapy Options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2019)... ... 26, 2019 , ... Alice Branton today released research results from preclinical trials ... Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The preclinical trial ... in crystallite size , Over 142% increase in particle size , ...
(Date:6/12/2019)... ... June 12, 2019 , ... Leak Detection Associates (LDA), the ... Biotechnology, Medical Device and Food Packaging Industries, is excited to announce that a ... exclusive rights for Zillion to represent LDA in all of China. , ...
(Date:6/11/2019)... REDWOOD CITY, Calif. (PRWEB) , ... June 10, ... ... (IOPP) today announced IOPP will add 80 of its scientific journals to ... addition of physics-related content to DeepDyve’s continually expanding library of more than 20 ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study released today ... (MSC-EV) are able to incorporate into human CD34+ cells, modifying their gene expression ... also increased the cells’ ability to lodge into bone marrow. This research performed ...
Breaking Biology Technology:
(Date:6/11/2019)... ... June 10, 2019 , ... Improved Pharma LLC announces the publication ... of AAPS PharmSciTech. The article was published online on April 29th, 2019. The authors ... with Xiaoming Sean Chen of Purdue University. , The article is the most recent ...
(Date:6/6/2019)... ... 2019 , ... Pelican BioThermal , the global name ... center in Mexico City, Mexico. Mexico is the second largest pharmaceutical market in ... billion in pharmaceutical exports since 2015. The Mexico City network station will service, ...
(Date:6/4/2019)... ... June 04, 2019 , ... In’Tech Medical ... today announced Q1-19 revenues of $31M, up 12% from Q1-18. The growth is ... strategic investments & operational excellence initiatives worldwide. , Laurent Pruvost , President ...
Breaking Biology News(10 mins):